Início › Câncer de Pulmão de Não Pequenas Células › Flórida › Deltona
Ensaios clínicos de Câncer de Pulmão de Não Pequenas Células em Deltona, FL
15 estudos para Câncer de Pulmão de Não Pequenas Células estão buscando participantes em locais em Deltona e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
RecrutandoFase 1/2
- Mid Florida Hematology And Oncology Center /ID# 273777, Orange City · a 4 mi de distância
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
RecrutandoFase 3
- Mid Florida Hematology and Oncology Center ( Site 0018), Orange City · a 4 mi de distância
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecrutandoFase 3
- Alpha Clinical Research Centers LLC, Orange City · a 4 mi de distância
- Florida Cancer Specialists, Orange City · a 4 mi de distância
- Mid Florida Hematology and Oncology Center, Orange City · a 4 mi de distância
- e mais 1
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RecrutandoFase 3
- Mid Florida Hematology and Oncology Center, Orange City · a 4 mi de distância
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
RecrutandoFase 1/2
- Mid Florida Hematology and Oncology Center, Orange City · a 4 mi de distância
Pan-tumor MRD Study
RecrutandoEstudo observacional
- Mid Florida Cancer Centers, Orange City · a 4 mi de distância
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
RecrutandoFase 3
- Research Site, Orange City · a 4 mi de distância
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
RecrutandoFase 2/3
- Mid Florida Cancer Centers, Orange City · a 4 mi de distância
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
RecrutandoFase 3
- Mid Florida Hematology and Oncology Center, Orange City · a 4 mi de distância
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
RecrutandoFase 3
- Mid Florida Hematology and Oncology Center, Orange City · a 4 mi de distância
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RecrutandoFase 2/3
- Local Institution - 007-926-B, Daytona Beach · a 26 mi de distância
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
RecrutandoFase 3
- Mid-Florida Hematology & Oncology Centers, P.A., Orange City · a 4 mi de distância
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
RecrutandoFase 3
- Research Site, Orange City · a 4 mi de distância
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RecrutandoFase 1/2
- Mid Florida Hematology and Oncology Center, Orange City · a 4 mi de distância
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
RecrutandoFase 2
- Mid Florida Hematology and Oncology Center, Orange City · a 4 mi de distância
Ensaios de Câncer de Pulmão de Não Pequenas Células em outras cidades
- Houston, TX145 estudos
- New York City, NY120 estudos
- Arlington, VA104 estudos
- Nashville, TN97 estudos
- Boston, MA90 estudos
- Los Angeles, CA87 estudos
- St. Louis, MO73 estudos
- Chicago, IL61 estudos
- Baltimore, MD60 estudos
- San Antonio, TX59 estudos
- Columbus, OH56 estudos
- Washington, DC55 estudos
Outros estudos em Deltona
- Obesidade11 estudos
- Diabetes tipo 210 estudos
- Doença de Alzheimer10 estudos
- Sobrepeso9 estudos
- Câncer de Mama8 estudos
- Câncer de Pulmão8 estudos
- Câncer (todos os tipos)7 estudos
- Pressão Alta5 estudos
- Osteoartrite do Joelho5 estudos
- Câncer Metastático5 estudos
- Melanoma5 estudos
- DPOC4 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.